Skip to content
  • My Cytovance
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Gene Therapy
    • Pre-Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us
  • My Cytovance
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Gene Therapy
    • Pre-Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us

Publications Library

Your Molecule Has Met Its Match

Filter by:

Loading...

An Integrated Single-Use Platform for Manufacturing Plasmid DNA (pDNA)

View Publication

Characterization of a Low Molecular Weight Product-related Impurity in a Manufactured Fc-Fusion Protein

View Publication
View Publication

A Strategic Partnership Delivers Innovation, Efficiency In Biotechnology Manufacturing Training

View Publication
View Publication

Cytograde™ pDNA: Manufacture pDNA Without Sacrificing Quality Or Budget

View Publication
View Publication

Embracing A New Standard For Regulatory Development: 3 Key Considerations For Phase-Appropriate GMPs

View Publication
View Publication

Comparison of different methods of clarification of CHO cells

View Publication
View Publication

Cloning of Three Cell Types Comparing the Namo™ Single Cell Dispenser to Flow Cytometry and Limited Dilution Cloning

View Publication
View Publication

Upstream development of Escherichia coli fermentation process with PhoA promoter using design of experiments (DoE)

View Publication
View Publication

Current perspectives on biosimilars

View Publication
View Publication

Improving Protein Folding Control and Scalability Using ImPULSE Mixing Technology From DNA Sequence to GMP Manufacturing

View Publication

CMO’s Cannot Produce SP2/0 Working Cell Bank: Cytovance Identifies Problem and Successfully Produces WCB

View Publication
View Publication

Rapid 200 Fold Scale-Up of a Fed-Batch Bioreactor Process for a CHO Cell Line expressing a Mab

View Publication
View Publication

End of content

No more pages to load

1 2 3 Next »
Subscribe to our Newsletter

Vision Statement

We believe in a healthier world where every biologic’s path to commercialization is advanced by a development and manufacturing partner that delivers ingenuity end-to-end.

  • CDMO Services
  • Your Partner
  • Knowledge Library
  • Careers
  • Contact Us
  • My Cytovance

© 2023 Cytovance Biologics